RENAISSANCE TECHNOLOGIES LLC
Position in ORGO — Organogenesis Holdings Inc.
CIK 1037389
NEW YORK, NY
Position in ORGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,471,584
-$60,851 QoQ
Shares Held
1,017,113
-4.8% QoQ
Ownership
0.790%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. ORGO ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in ORGO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,471,584 | 1,017,113 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,532,435 | 1,068,538 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,240,866 | 818,700 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,466,730 | 821,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,942,274 | 803,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,507,920 | 1,043,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,435,200 | 1,073,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,339,194 | 817,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,227,960 | 795,700 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,292,164 | 807,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,508,095 | 857,725 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,175,418 | 684,094 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,344,258 | 706,102 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,659,092 | 1,248,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,156,440 | 1,173,398 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,832,920 | 1,183,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,304,336 | 472,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,634,996 | 345,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,160,544 | 125,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,263,104 | 369,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,786,904 | 709,200 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,551,758 | 688,900 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,866,639 | 646,300 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $736,512 | 191,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $516,480 | 134,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $218,348 | 67,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||